Carol A Langford

Carol A Langford

UNVERIFIED PROFILE

Are you Carol A Langford?   Register this Author

Register author
Carol A Langford

Carol A Langford

Publications by authors named "Carol A Langford"

Are you Carol A Langford?   Register this Author

100Publications

2645Reads

24Profile Views

Disease Activity, ANCA-Type, and Lipid Levels in ANCA-Associated Vasculitis.

Arthritis Rheumatol 2019 Jun 4. Epub 2019 Jun 4.

Clinical Rheumatology, Massachusetts General Hospital, 55 Fruit Street / Yawkey 2, 02114, Boston, Massachusetts, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.41006DOI Listing
June 2019

Feasibility and Construct Validation of the Patient Reported Outcomes Measurement Information System in Systemic Vasculitis.

J Rheumatol 2019 Mar 1. Epub 2019 Mar 1.

From the Department of Epidemiology and Biostatistics, Faculty of Medicine, University of Iceland; Department of Rheumatology, and Centre for Rheumatology Research, University Hospital, Reykjavik, Iceland; Department of Biostatistics, Epidemiology, and Informatics, and Division of Rheumatology, and Department of Family Medicine and Community Health, and Division of General Internal Medicine, University of Pennsylvania, Philadelphia; Division of Rheumatology, University of Pittsburgh, Pittsburgh, Pennsylvania; Department of Biostatistics and Informatics, Department of Pediatrics, University of South Florida, Tampa, Florida; Division of Rheumatology, University of Utah, Salt Lake City, Utah; Department of Rheumatology, Cleveland Clinic, Cleveland; Ohio State University Wexner Medical Center, Columbus, Ohio; Section of Rheumatology, Boston University School of Medicine, Boston, Massachusetts; Division of Rheumatology, and Division of Pulmonology and Critical Care Medicine, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA; Nuffield Department of Population Health, Health Services Research Unit (HSRU), and Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford; Faculty of Health and Applied Sciences, University of the West of England, Bristol and School of Clinical Sciences, University of Bristol, Bristol, UK; Department of Rheumatology, University of Ottawa, Ottawa; Division of Rheumatology, Mount Sinai Hospital, Toronto; Division of Rheumatology, St. Joseph's Healthcare, McMaster University, Hamilton, Ontario, Canada. This work was supported by The Vasculitis Clinical Research Consortium (VCRC; U54 AR057319 and R01 AR 064153), which is part of the Rare Diseases Clinical Research Network, an initiative of the US Office of Rare Diseases Research, National Center for Advancing Translational Science (NCATS). The VCRC is funded through collaboration between NCATS, and the National Institute of Arthritis and Musculoskeletal and Skin Diseases, and has received funding from the National Center for Research Resources (U54 RR019497). Additional support for this work was provided by a contract from the Patient-Centered Outcomes Research Institute (IP2PI000603). G. Tomasson, MD, PhD, Assistant Professor, Department of Epidemiology and Biostatistics, Faculty of Medicine, University of Iceland, and Department of Rheumatology, and Centre for Rheumatology Research, University Hospital; J.T. Farrar, MD, Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania; D. Cuthbertson, MS, Department of Biostatistics and Informatics, Department of Pediatrics, University of South Florida; C.A. McAlear, MA, Division of Rheumatology, University of Pennsylvania; S. Ashdown, RN, Oxfordshire; P.F. Cronholm, MD, MSCE, Department of Family Medicine and Community Health, University of Pennsylvania; J. Dawson, MA, MSc, DPhil, SRN, SCM, Nuffield Department of Population Health (HSRU), University of Oxford; D. Gebhart, MD, Ohio State University Wexner Medical Center, Columbus; G. Lanier, Patient Research Partner, Boston; R.A. Luqmani, DM, FRCP, FRCP(E), Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford; N. Milman, MD, MSc, FRCPC, Department of Rheumatology, University of Ottawa; J. Peck, RN, Faculty of Health and Applied Sciences, University of the West of England, Bristol and School of Clinical Sciences, University of Bristol; J.A. Shea, PhD, Division of General Internal Medicine, University of Pennsylvania; S. Carette, MD, Division of Rheumatology, Mount Sinai Hospital; N. Khalidi, MD, Division of Rheumatology, St. Joseph's Healthcare, McMaster University; C.L. Koening, MD, Division of Rheumatology, University of Utah; C.A. Langford, MD, Department of Rheumatology, Cleveland Clinic; P.A. Monach, MD, PhD, Section of Rheumatology, Boston University School of Medicine; L. Moreland, MD, Division of Rheumatology, University of Pittsburgh; C. Pagnoux, MD, MSc, MPH, Division of Rheumatology, Mount Sinai Hospital; U. Specks, MD, Division of Pulmonology and Critical Care Medicine, Mayo Clinic College of Medicine and Science; A.G. Sreih, MD, Division of Rheumatology, University of Pennsylvania; S.R. Ytterberg, MD, Division of Rheumatology, Mayo Clinic College of Medicine and Science; P.A. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania. Address correspondence to Dr. G. Tomasson, Department of Epidemiology and Biostatistics, Faculty of Medicine, University of Iceland, Sturlugata 8, 101 Reykjavik, Iceland. E-mail: Accepted for publication November 26, 2018.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.171405DOI Listing
March 2019

Reply.

Arthritis Rheumatol 2017 07 10;69(7):1505-1506. Epub 2017 May 10.

University of Pennsylvania, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.40107DOI Listing
July 2017

Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis.

N Engl J Med 2017 05;376(20):1921-1932

From the Department of Medicine, National Jewish Health, Denver (M.E.W.); the Division of Pulmonary, Critical Care, and Sleep Medicine, University of California San Diego, La Jolla (P.A.); Beth Israel Deaconess Medical Center, Boston (P.A., P.F.W.); the Department of Medicine, University of Cambridge, Cambridge (D.J.), the Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, Botnar Research Centre, University of Oxford, Oxford (R.L.), Research and Development, Immuno-Inflammation Therapy Area Unit (J.B.), and Research and Development, Statistics, Programming, and Data Standards (S.M.), GlaxoSmithKline, Uxbridge, and Trizell, Oxford (R.P.) - all in the United Kingdom; the Human Eosinophil Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD (P.K., A.K.); the Center for Vasculitis Care and Research, Cleveland Clinic, Cleveland (C.A.L.); the Division of Rheumatology and the Department of Biostatistics and Clinical Epidemiology, University of Pennsylvania (P.A.M.), and the Respiratory Therapy Area Unit and Flexible Discovery Unit, GlaxoSmithKline (J.S.), Philadelphia; Rheumazentrum, Schleswig-Holstein Mitte, Neumünster, Germany (F.M.); the Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN (U.S.); the Vasculitis Research Unit, Department of Autoimmune Diseases, Hospital Clinic University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona (M.C.C.); the Respiratory Therapeutic Area, GlaxoSmithKline, Research Triangle Park, NC (S.W.Y.); and the Departments of Dermatology and Medicine, University of Utah School of Medicine, Salt Lake City (G.J.G.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1702079DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548295PMC
May 2017

Sinonasal imaging findings in granulomatosis with polyangiitis (Wegener granulomatosis): A systematic review.

Am J Rhinol Allergy 2017 Jan;31(1):16-21

Division of Rhinology, Allergy, and Skull Base Surgery, ENT Institute, University Hospitals, Case Western Reserve University, Cleveland, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2500/ajra.2017.31.4408DOI Listing
January 2017

The Birmingham Vasculitis Activity Score as a Measure of Disease Activity in Patients with Giant Cell Arteritis.

J Rheumatol 2016 06 1;43(6):1078-84. Epub 2016 Apr 1.

From the Division of Rheumatology, University of California, Los Angeles, Los Angeles, California; Department of Biostatistics, University of South Florida, Tampa, Florida, USA; Division of Rheumatology, Mount Sinai Hospital, Toronto, Ontario, Canada; Center for Vasculitis Care and Research, Cleveland Clinic, Cleveland, Ohio, USA; Division of Rheumatology, St. Joseph's Healthcare, McMaster University, Hamilton, Ontario, Canada; Division of Rheumatology, University of Utah, Salt Lake City, Utah; Division of Rheumatology, University of Pittsburgh, Pittsburgh, Pennsylvania; Division of Rheumatology and Clinical Immunology, University of Pennsylvania, Philadelphia, Pennsylvania; The Vasculitis Center, Section of Rheumatology, and the Clinical Epidemiology Unit, Boston University School of Medicine, Boston, Massachusetts; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland; Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.T.A. Kermani, MD, MS, Division of Rheumatology, University of California, Los Angeles; D. Cuthbertson, MS, Department of Biostatistics, University of South Florida; S. Carette, MD, FRCPC, Division of Rheumatology, Mount Sinai Hospital; G.S. Hoffman, MD, MS, Center for Vasculitis Care and Research, Cleveland Clinic; N.A. Khalidi, MD, FRCPC, Division of Rheumatology, St. Joseph's Healthcare, McMaster University; C.L. Koening, MD, MS, Division of Rheumatology, University of Utah; C.A. Langford, MD, MHS, Center for Vasculitis Care and Research, Cleveland Clinic; K. McKinnon-Maksimowicz, DO, Division of Rheumatology, University of Pittsburgh; C.A. McAlear, MA, Division of Rheumatology and Clinical Immunology, University of Pennsylvania; P.A. Monach, MD, PhD, The Vasculitis Center, Section of Rheumatology, and the Clinical Epidemiology Unit, Boston University School of Medicine; P. Seo, MD, MHS, Division of Rheumatology, Johns Hopkins University; K.J. Warrington, MD, Division of Rheumatology, Mayo Clinic

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.151063DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891218PMC
June 2016

Vasculitis in patients with inflammatory bowel diseases: A study of 32 patients and systematic review of the literature.

Semin Arthritis Rheum 2016 Feb 26;45(4):475-82. Epub 2015 Jul 26.

Division of Rheumatology, Mount Sinai Hospital, University of Toronto, The Joseph and Wolf Lebovic Building, 60 Murray St, Ste 2-220, Toronto, Ontario, Canada M5T 3L9. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semarthrit.2015.07.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982464PMC
February 2016

A 39-Year-Old Postpartum Woman With Foot Drop and Shortness of Breath.

Chest 2016 Feb;149(2):e61-e64

Respiratory Institute, Cleveland Clinic Foundation, Cleveland, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.chest.2015.10.051DOI Listing
February 2016

Eosinophilia in Rheumatologic/Vascular Disorders.

Immunol Allergy Clin North Am 2015 Aug 17;35(3):453-76. Epub 2015 Jun 17.

Department of Rheumatic and Immunologic Diseases, Center for Vasculitis Care and Research, Cleveland Clinic, 9500 Euclid Avenue, A50, Cleveland, OH 44195, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.iac.2015.05.001DOI Listing
August 2015

Disease Relapses among Patients with Giant Cell Arteritis: A Prospective, Longitudinal Cohort Study.

J Rheumatol 2015 Jul 15;42(7):1213-7. Epub 2015 Apr 15.

From the Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota; Department of Biostatistics, University of South Florida, Tampa, Florida, USA; Division of Rheumatology, Mount Sinai Hospital, Toronto, Ontario, Canada; Center for Vasculitis Care and Research, Cleveland Clinic, Cleveland, Ohio, USA; Division of Rheumatology, St. Joseph's Healthcare, McMaster University, Hamilton, Ontario, Canada; Division of Rheumatology, University of Utah, Salt Lake City, Utah; Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania; The Vasculitis Center, Section of Rheumatology, Boston University School of Medicine, Boston, Massachusetts; Division of Rheumatology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland; University of California at Los Angeles (UCLA), Los Angeles, California, USA.T.A. Kermani, MD, MS, UCLA; K.J. Warrington, MD, Division of Rheumatology, Mayo Clinic College of Medicine; D. Cuthbertson, MS, Department of Biostatistics, University of South Florida; S. Carette, MD, FRCPC, Division of Rheumatology, Mount Sinai Hospital; G.S. Hoffman, MD, MS, Center for Vasculitis Care and Research, Cleveland Clinic; N.A. Khalidi, MD, FRCPC, Division of Rheumatology, St. Joseph's Healthcare, McMaster University; C.L. Koening, MD, MS, Division of Rheumatology, University of Utah; C.A. Langford, MD, MHS, Center for Vasculitis Care and Research, Cleveland Clinic; K. Maksimowicz-McKinnon, DO, Division of Rheumatology and Clinical Immunology, University of Pittsburgh; C.A. McAlear, MA, The Vasculitis Center, Section of Rheumatology, Boston University School of Medicine, and Division of Rheumatology, University of Pennsylvania School of Medicine; P.A. Monach, MD, PhD, The Vasculitis Center, Section of Rheumatology, Boston University School of Medicine; P. Seo, MD, MHS, Division of Rheumatology, Johns Hopkins University

View Article

Download full-text PDF

Source
http://www.jrheum.org/content/42/7/1213.full.pdf
Web Search
http://www.jrheum.org/cgi/doi/10.3899/jrheum.141347
Publisher Site
http://dx.doi.org/10.3899/jrheum.141347DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4505815PMC
July 2015

Cardiac Involvement in Granulomatosis with Polyangiitis.

J Rheumatol 2015 Jul 1;42(7):1209-12. Epub 2015 May 1.

From the Division of Rheumatology, Mount Sinai Hospital, Toronto, Ontario, Canada; Health Informatics Institute, University of South Florida, Tampa, Florida; Center for Vasculitis Care and Research, Cleveland Clinic, Cleveland, Ohio, USA; Division of Rheumatology, McMaster University, Hamilton, Ontario, Canada; Division of Rheumatology, University of Utah, Salt Lake City, Utah; Division of Rheumatology, University of Pennsylvania, Philadelphia; Division of Rheumatology, University of Pittsburgh, Pennsylvania; The Vasculitis Center, Section of Rheumatology, and the Clinical Epidemiology Unit, Boston University School of Medicine, Boston, Massachusetts; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland; Division of Pulmonary and Critical Care Medicine, and the Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.L. McGeoch, MD; S. Carette, MD, Division of Rheumatology, Mount Sinai Hospital; D. Cuthbertson, MS, Health Informatics Institute, University of South Florida; G.S. Hoffman, MD, Center for Vasculitis Care and Research, Cleveland Clinic; N. Khalidi, MD, Division of Rheumatology, McMaster University; C.L. Koening, MD, Division of Rheumatology, University of Utah; C.A. Langford, MD, Center for Vasculitis Care and Research, Cleveland Clinic; C.A. McAlear, MA, Division of Rheumatology, University of Pennsylvania; L. Moreland, MD, Division of Rheumatology, University of Pittsburgh; P.A. Monach, MD, PhD, The Vasculitis Center, Section of Rheumatology, and the Clinical Epidemiology Unit, Boston University School of Medicine; P. Seo, MD, Division of Rheumatology, Johns Hopkins University; U. Specks, MD, Division of Pulmonary and Critical Care Medicine; S.R. Ytterberg, MD, Division of Rheumatology, Mayo Clinic College of Medicine; P.A. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania; C. Pagnoux, MD, MSc, MPH, Division of Rheumatology, Mount Sinai Hospital.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.141513DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4505809PMC
July 2015

Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement.

J Am Soc Nephrol 2015 Apr 7;26(4):976-85. Epub 2014 Nov 7.

Division of Pulmonary and Critical Care Medicine and Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, Rochester, Minnesota;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1681/ASN.2014010046DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378104PMC
April 2015

A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility.

Am J Hum Genet 2015 Apr 26;96(4):565-80. Epub 2015 Mar 26.

Instituto de Parasitología y Biomedicina "López-Neyra," CSIC, PTS Granada, Granada 18016, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajhg.2015.02.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385191PMC
April 2015

Granulomatosis with polyangiitis (Wegener's): impact of maintenance therapy duration.

Medicine (Baltimore) 2014 Mar;93(2):82-90

From Department of Rheumatic and Immunologic Diseases (JS); Department of Quantitative Health Sciences (BN); and Center for Vasculitis Care and Research, Department of Rheumatic and Immunologic Diseases (CAL, GSH, AVF), Cleveland Clinic, Cleveland, Ohio. *Current affiliation: University of Kansas Medical Center, Kansas City, Kansas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000000020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616311PMC
March 2014

New features of disease after diagnosis in 6 forms of systemic vasculitis.

J Rheumatol 2013 Nov 1;40(11):1905-12. Epub 2013 Aug 1.

From The Vasculitis Center, Section of Rheumatology, and the Clinical Epidemiology Unit, Boston University School of Medicine, Boston, Massachusetts; Department of Biostatistics, University of South Florida, Tampa, Florida; Division of Rheumatology, Mount Sinai Hospital, Toronto, Ontario; and the Center for Vasculitis Care and Research, Cleveland Clinic, Cleveland, Ohio; Division of Rheumatology, McMaster University, Hamilton, Ontario, Canada; Division of Rheumatology, University of Utah, Salt Lake City, Utah; Division of Rheumatology, University of Pittsburgh; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland; Division of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine, Rochester; Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota; and Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.121473DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292850PMC
November 2013

L41. Perspectives on the treatment of giant cell arteritis.

Authors:
Carol A Langford

Presse Med 2013 Apr 9;42(4 Pt 2):609-12. Epub 2013 Mar 9.

Center for Vasculitis Care and Research, Cleveland Clinic, Department of Rheumatic and Immunologic Diseases, Cleveland, OH 44195, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lpm.2013.02.306DOI Listing
April 2013

Distribution of arterial lesions in Takayasu's arteritis and giant cell arteritis.

Ann Rheum Dis 2012 Aug 10;71(8):1329-34. Epub 2012 Feb 10.

The Vasculitis Center, Section of Rheumatology, and the Clinical Epidemiology Unit, Boston University School of Medicine, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2011-200795DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3729734PMC
August 2012

Update on the treatment of granulomatosis with polyangiitis (Wegener's).

Authors:
Carol A Langford

Curr Treat Options Cardiovasc Med 2012 Apr;14(2):164-76

Center for Vasculitis Care and Research, Department of Rheumatologic and Immunologic Disease, Cleveland Clinic, 9500 Euclid Avenue, A50, Cleveland, OH, 44195, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11936-012-0165-xDOI Listing
April 2012

A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis.

Arthritis Rheum 2012 Mar;64(3):835-42

Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20854, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/art.34322
Publisher Site
http://dx.doi.org/10.1002/art.34322DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3243106PMC
March 2012

Serum chitotriosidase activity and Wegener's granulomatosis.

Clin Biochem 2010 Mar 1;43(4-5):512-4. Epub 2009 Dec 1.

Department of Rheumatic and Immunologic Diseases, Cleveland Clinic Center for Vasculitis Care and Research, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinbiochem.2009.11.015DOI Listing
March 2010

Vasculitis.

Authors:
Carol A Langford

J Allergy Clin Immunol 2010 Feb 24;125(2 Suppl 2):S216-25. Epub 2009 Nov 24.

Center for Vasculitis Care and Research, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://www.vasculitis.org.uk/content/downloads/1-route-map-j
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S009167490900999
Publisher Site
http://dx.doi.org/10.1016/j.jaci.2009.07.002DOI Listing
February 2010

A 72-year-old man with a purpuric rash.

Cleve Clin J Med 2009 Jun;76(6):353-60

Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3949/ccjm.76a.09141DOI Listing
June 2009

Update on vasculitis.

J Allergy Clin Immunol 2009 Jun;123(6):1226-36

Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaci.2009.04.024DOI Listing
June 2009

Drug insight: anti-tumor necrosis factor therapies for the vasculitic diseases.

Authors:
Carol A Langford

Nat Clin Pract Rheumatol 2008 Jul 27;4(7):364-70. Epub 2008 May 27.

Center for Vasculitis Care and Research, Department of Rheumatic and Immunologic Diseases at Cleveland Clinic, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncprheum0825DOI Listing
July 2008

Balancing efficacy and cancer risk of cyclophosphamide for patients with Wegener's granulomatosis.

Nat Clin Pract Rheumatol 2008 Jul 27;4(7):340-1. Epub 2008 May 27.

Center for Vasculitis Care and Research, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, OH 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncprheum0822DOI Listing
July 2008

Intravenous immunoglobulin in Wegener's granulomatosis and microscopic polyangiitis.

Arthritis Rheum 2008 Jul;58(7):2211-2; author reply 2212

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.23587DOI Listing
July 2008

Takayasu's arteritis.

Curr Treat Options Cardiovasc Med 2008 Apr;10(2):164-72

University of Utah, Division of Rheumatology, Room 4b200 SOM, 1900 East 30 North, Salt Lake City, UT 84132, USA.

View Article

Download full-text PDF

Source
April 2008

Does the dose of methotrexate influence the rate of relapse in patients with Wegener's granulomatosis?

Nat Clin Pract Rheumatol 2008 Jan;4(1):12-3

Center for Vasculitis Care and Research, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, Ohio 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncprheum0675DOI Listing
January 2008

Vasculitis mimics.

Curr Opin Rheumatol 2008 Jan;20(1):29-34

Center for Vasculitis Care and Research, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, Ohio 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/BOR.0b013e3282f1dcf2DOI Listing
January 2008

Small-vessel vasculitis: therapeutic management.

Authors:
Carol A Langford

Curr Rheumatol Rep 2007 Aug;9(4):328-35

Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
August 2007

Should induction therapy with high-dose glucocorticoids be the standard treatment for all patients with giant cell arteritis?

Nat Clin Pract Rheumatol 2007 Mar;3(3):132-3

Center for Vasculitis Care and Research, Cleveland Clinic Foundation, Lerner College of Medicine, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncprheum0425DOI Listing
March 2007

Vasculitis in the geriatric population.

Authors:
Carol A Langford

Rheum Dis Clin North Am 2007 Feb;33(1):177-95

Center for Vasculitis Care and Research, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, 9500 Euclid Avenue, A50, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rdc.2006.12.002DOI Listing
February 2007

Advances in the treatment of small vessel vasculitis.

Rheum Dis Clin North Am 2006 Feb;32(1):157-72, x

Department of Clinical Pharmacology, Royal College of Surgeons in Ireland, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rdc.2005.12.002DOI Listing
February 2006

Novel therapeutic strategies for large vessel vasculitis.

Rheum Dis Clin North Am 2006 Feb;32(1):173-86, xi

Center for Vasculitis Care and Research, Department of Rheumatic and Immunologic Diseases, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rdc.2005.09.006DOI Listing
February 2006

Can methotrexate replace cyclophosphamide in the treatment of a subset of Wegener's granulomatosis and microscopic polyangiitis?

Nat Clin Pract Rheumatol 2006 Feb;2(2):70-1

Cleveland Clinic Foundation, OH 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncprheum0100DOI Listing
February 2006

Vasculitis in the geriatric population.

Authors:
Carol A Langford

Clin Geriatr Med 2005 Aug;21(3):631-47, viii

Center for Vasculitis Care and Research, Department of Rheumatic and Immunologic Diseases, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S074906900500014
Publisher Site
http://dx.doi.org/10.1016/j.cger.2005.02.011DOI Listing
August 2005

Update on Wegener granulomatosis.

Authors:
Carol A Langford

Cleve Clin J Med 2005 Aug;72(8):689-90, 693-7

Center for Vasculitis Care and Research, Department of Rheumatic and Immunologic Diseases, The Cleveland Clinic Foundation, OH 44195, USA.

View Article

Download full-text PDF

Source
August 2005

How can relapses be detected and prevented in primary systemic small-vessel vasculitides?

Authors:
Carol A Langford

Best Pract Res Clin Rheumatol 2005 Apr;19(2):307-20

Department of Rheumatic and Immunologic Diseases, The Cleveland Clinic Foundation, 9500 Euclid Avenue, A50, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.berh.2004.11.003DOI Listing
April 2005

Polyarteritis nodosa reports to the vaccine adverse event reporting system (VAERS): implications for assessment of suspected vaccine-provoked vasculitis.

J Rheumatol 2004 Nov;31(11):2181-8

Vaccine Safety Branch, Division of Epidemiology, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, Maryland 20852-1448, USA.

View Article

Download full-text PDF

Source
November 2004

Wegener's granulomatosis: evolving concepts in treatment.

Semin Respir Crit Care Med 2004 Oct;25(5):491-521

Department of Medicine, Division of Pulmonary, Critical Care Medicine, and Hospitalists, The David Geffen School of Medicine at UCLA, Los Angeles, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-2004-836143DOI Listing
October 2004

Biologic immunomodulatory therapies in the vasculitic diseases.

Authors:
Carol A Langford

Semin Respir Crit Care Med 2004 Oct;25(5):595-607

Center for Vasculitis Care and Research, Department of Rheumatic and Immunologic Diseases, The Cleveland Clinic Foundation, Cleveland, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-2004-836150DOI Listing
October 2004

Mycophenolate mofetil for remission maintenance in the treatment of Wegener's granulomatosis.

Arthritis Rheum 2004 Apr;51(2):278-83

National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.20240DOI Listing
April 2004

Wegener's granulomatosis: current and upcoming therapies.

Authors:
Carol A Langford

Arthritis Res Ther 2003 29;5(4):180-91. Epub 2003 May 29.

Immunologic Diseases Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/ar771DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC165064PMC
November 2003

Tarsal-conjunctival disease associated with Wegener's granulomatosis.

Ophthalmology 2003 Sep;110(9):1770-80

National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0161-6420(03)00616-XDOI Listing
September 2003

Treatment of ANCA-associated vasculitis.

Authors:
Carol A Langford

N Engl J Med 2003 Jul;349(1):3-4

Immunologic Diseases Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMp030047DOI Listing
July 2003

New insights into the immunopathogenesis and treatment of small vessel vasculitis of the kidney.

Curr Opin Nephrol Hypertens 2003 May;12(3):267-72

Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892-1818, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.mnh.0000069857.94246.e5DOI Listing
May 2003

Use of a cyclophosphamide-induction methotrexate-maintenance regimen for the treatment of Wegener's granulomatosis: extended follow-up and rate of relapse.

Am J Med 2003 Apr;114(6):463-9

National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0002-9343(03)00077-9DOI Listing
April 2003

15. Vasculitis.

Authors:
Carol A Langford

J Allergy Clin Immunol 2003 Feb;111(2 Suppl):S602-12

Immunologic Diseases Section, National Institute of Allergy and Infectious Diseases/NIH, Building 10, Room 11B-13, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
February 2003

Biologic therapies in the vasculitides.

Curr Opin Rheumatol 2003 Jan;15(1):3-10

Immunologic Diseases Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
January 2003

CT virtual bronchoscopy of the central airways in patients with Wegener's granulomatosis.

Chest 2002 Jan;121(1):242-50

Diagnostic Radiology Department, Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892-1182, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1378/chest.121.1.242DOI Listing
January 2002